Portside Wealth Group LLC Has $849,000 Stake in CME Group Inc. (NASDAQ:CME)

Portside Wealth Group LLC grew its stake in CME Group Inc. (NASDAQ:CME) by 55.2% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 3,848 shares of the financial services provider’s stock after buying an additional 1,368 shares during the period. Portside Wealth Group LLC’s holdings in CME Group were worth $849,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in CME. Norden Group LLC bought a new stake in shares of CME Group during the 1st quarter worth $274,000. Private Advisor Group LLC boosted its holdings in CME Group by 3.9% during the first quarter. Private Advisor Group LLC now owns 4,592 shares of the financial services provider’s stock valued at $989,000 after acquiring an additional 172 shares during the period. Duality Advisers LP acquired a new stake in shares of CME Group in the first quarter valued at about $1,455,000. Empowered Funds LLC grew its position in shares of CME Group by 24.5% in the first quarter. Empowered Funds LLC now owns 5,596 shares of the financial services provider’s stock valued at $1,205,000 after purchasing an additional 1,101 shares during the last quarter. Finally, SG Americas Securities LLC increased its stake in shares of CME Group by 312.2% in the first quarter. SG Americas Securities LLC now owns 56,768 shares of the financial services provider’s stock worth $12,222,000 after purchasing an additional 42,996 shares during the period. Institutional investors own 87.75% of the company’s stock.

Insider Transactions at CME Group

In related news, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the sale, the director now directly owns 55,607 shares in the company, valued at $11,932,706.13. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other news, Director Martin J. Gepsman sold 400 shares of the company’s stock in a transaction that occurred on Monday, November 4th. The shares were sold at an average price of $222.92, for a total transaction of $89,168.00. Following the transaction, the director now directly owns 25,067 shares in the company, valued at approximately $5,587,935.64. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the sale, the director now directly owns 55,607 shares in the company, valued at $11,932,706.13. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 15,621 shares of company stock valued at $3,441,063. Corporate insiders own 0.30% of the company’s stock.

CME Group Stock Performance

Shares of NASDAQ:CME opened at $225.66 on Friday. The company has a debt-to-equity ratio of 0.09, a current ratio of 1.02 and a quick ratio of 1.02. The business’s fifty day moving average price is $221.72 and its two-hundred day moving average price is $209.91. CME Group Inc. has a fifty-two week low of $190.70 and a fifty-two week high of $230.36. The stock has a market capitalization of $81.26 billion, a price-to-earnings ratio of 23.73, a price-to-earnings-growth ratio of 5.61 and a beta of 0.55.

CME Group (NASDAQ:CME) last posted its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share for the quarter, topping the consensus estimate of $2.65 by $0.03. The business had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.59 billion. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The firm’s quarterly revenue was up 18.4% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $2.25 EPS. As a group, analysts predict that CME Group Inc. will post 10.23 EPS for the current fiscal year.

CME Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Monday, December 9th will be paid a dividend of $1.15 per share. The ex-dividend date is Monday, December 9th. This represents a $4.60 annualized dividend and a yield of 2.04%. CME Group’s dividend payout ratio is 48.37%.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on the company. TD Cowen started coverage on CME Group in a report on Thursday, September 26th. They issued a “hold” rating and a $221.00 target price on the stock. Morgan Stanley raised their price objective on shares of CME Group from $210.00 to $233.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 17th. Royal Bank of Canada reiterated a “sector perform” rating and set a $235.00 target price on shares of CME Group in a research note on Thursday, October 24th. The Goldman Sachs Group raised their price target on shares of CME Group from $195.00 to $198.00 and gave the stock a “sell” rating in a research report on Thursday, October 3rd. Finally, Keefe, Bruyette & Woods upped their price objective on shares of CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a research report on Thursday, July 25th. Four investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have given a buy rating to the company’s stock. According to MarketBeat.com, CME Group presently has a consensus rating of “Hold” and a consensus target price of $222.73.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.